Entrada Therapeutics amends 2021 stock plan to increase share reserve.

Entrada Therapeutics amended its 2021 Stock Option and Incentive Plan to raise the maximum share reserve to 3.9 million shares with 4% annual increases. The amendment was approved by the board on March 26, 2026 and by stockholders on June 10, 2026.